Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
Britain Courts Anthropic Amid US Defense Department Dispute 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
NEW YORK, June 20, 2017 -- Luxury mattress manufacturer Unicorn Sleep says there is hope for patients with stage IV breast cancer.
“We believe in the power of research,” explained Unicorn Sleep CEO Chris Syed. “When properly funded, more life-extending treatments and therapies for stage IV breast cancer will be found.”
To help fund that research, Unicorn Sleep recently introduced a METAvivor mattress. The company donates 30 percent of profits from those sales to the charity METAvivor. METAvivor is a patient-led, non-profit organization that funds research, raises awareness, advocates for, and provides support to people with stage IV (metastatic) breast cancer.
“We at METAvivor are thrilled to partner with Unicorn Sleep. The generosity, care and concern of this company is humbling. Unicorn Sleep understands that research will make a difference for stage IV metastatic breast cancer. And for those patients who have bone metastasis it is really important to have a high quality mattress!” said METAvivor President Beth Fairchild.
Stage IV metastatic breast cancer (MBC) is defined by the spread of breast cancer to non-adjacent organs and is fatal in 97–99 percent of cases. In the U.S., more than 40,000 people die from MBC every year.
METAvivor awards grants for research projects that have the potential to shift MBC from a terminal disease to a chronic condition with a good quality of life. 100 percent of every donation given to METAvivor goes toward funding these grants.
“Unicorn Sleep was founded with the belief that good sleep is a vital part of good health and that giving back to the community is a responsibility we all share,” Syed explained. “The METAvivor mattress helps us achieve both.”
Unlike many direct-to-consumer mattress companies, Unicorn Sleep offers a choice of firmness. The handcrafted, 10-comfort-layer mattresses are built with the finest natural, high-quality components and include free white glove delivery and setup, removal, and a 150-night trial period—one of the longest in the industry.
About Unicorn Sleep
Unicorn Sleep produces all-natural, high-quality bedding products. Mattresses are delivered directly to the consumer via white glove delivery service and come with an industry-leading 150-night trial period. For more information, visit www.UnicornSleep.com.
Media Contact Jennifer Butsch Petit WordUp Public Relations [email protected] 757-656-9673
